Effects of Stress and Nicotine on ADHD Rat Models by Murthy, Krisha S.
Worcester Polytechnic Institute
Digital WPI
Major Qualifying Projects (All Years) Major Qualifying Projects
April 2006
Effects of Stress and Nicotine on ADHD Rat
Models
Krisha S. Murthy
Worcester Polytechnic Institute
Follow this and additional works at: https://digitalcommons.wpi.edu/mqp-all
This Unrestricted is brought to you for free and open access by the Major Qualifying Projects at Digital WPI. It has been accepted for inclusion in
Major Qualifying Projects (All Years) by an authorized administrator of Digital WPI. For more information, please contact digitalwpi@wpi.edu.
Repository Citation
Murthy, K. S. (2006). Effects of Stress and Nicotine on ADHD Rat Models. Retrieved from https://digitalcommons.wpi.edu/mqp-all/
3868
Project Number: BME-JMS-0602 
 
 Effects of Stress and Nicotine on 
ADHD Rat Models 
 
 
 
 
A Major Qualifying Report 
 
 
Submitted to the Faculty  
 
Of the  
 
Worcester Polytechnic Institute 
 
In Partial Fulfillment of the Requirements for the  
 
Degree of Bachelor of Science 
 
By 
 
 
__________________ 
 
Krisha S. Murthy 
 
Date: April 27, 2006 
 
Approved: 
 
 
 
 
 
 
       _____________________________ 
Professor John Sullivan, Major Advisor 
 
 
 
___________________ 
Dr. Jean King, Co-Advisor 
 2 
Table of Contents 
 
 
Acknowledgements .............................................................................. 3 
Table of Figures ................................................................................... 4 
Abstract................................................................................................ 6 
Introduction ........................................................................................ 7 
Background .................................................................................................. 7 
Animal Modeling ....................................................................................... 10 
Expected Results ........................................................................................ 12 
Methods .............................................................................................. 13 
Subjects ...................................................................................................... 13 
Equipment .................................................................................................. 13 
Behavioral ............................................................................................... 13 
fMRI ........................................................................................................ 14 
Procedure............................................................................................ 15 
Experimental Protocol Time Table ............................................................ 15 
fMRI ........................................................................................................... 15 
Acclimation Phase ................................................................................... 16 
Habituation Phase ...................................................................................... 16 
Sensitization ............................................................................................... 16 
Drug Administration ............................................................................... 16 
Stress Manipulation ................................................................................. 17 
Results ................................................................................................ 17 
Sensitization ............................................................................................... 17 
fMRI ........................................................................................................... 24 
Data Analysis ..................................................................................... 26 
Sensitization ............................................................................................... 26 
MRI ............................................................................................................ 28 
Conclusion ......................................................................................... 29 
References ......................................................................................... 30 
 
 3 
Acknowledgements 
 
Thank you to Professor John Sullivan and Dr. Jean King for their advising and 
support, and also to Praveen Kulkarni, Tim Garelick, Tara Messenger and Wei 
Chen for their time and help. 
 
 4 
Table of Figures 
 
 
Figure 1: This graph shows the high probability that a parent with ADHD will pass that disorder 
onto their offspring versus a parent without ADHD in three different studies...………………………...7 
 
Figure 2: This figure shows the expected movement of each of the six sets of rats versus time, with 
the time on the x-axis and the movement on the y-axis…..………………………………………………………13 
 
Figure 3: The animals were placed in the black box above to gather the behavioral data for this 
study…………………………………………………………………………………………………………………………………14 
 
Figure 4: Animals were secured with this multi-concentric dual-coil, small animal restrainer..…14 
 
Figure 5: Once the particular animal was secured, it was placed into the above magnet for 
fMRI………………………………………………………………………………………………………………………………...14 
 
Figure 6: This figure shows the movement for an n=4 of SD animals being injected with only 
saline. The movement stays basically constant at an average distance of 8500 cm…………………...18 
 
Figure 7: This figure shows the movement for an n=4 of WKY animals being injected with only 
saline. The movement stays basically constant at an average distance of 5000 cm……………………18 
 
Figure 8: This figure shows the movement for an n=4 of SHR animals being injected with only 
saline. The movement stays basically constant at an average distance of 8000 cm…………………...19 
 
Figure 9: This figure shows the movement for an n=4 of SD animals being injected with nicotine. 
The movement increases as the daily injections are given. The animal is sensitized by Day 6, when 
the movement stops increasing and around 11000 cm……………………………………………………………19 
 
Figure 10: This figure shows the movement for an n=4 of WKY animals being injected with 
nicotine. The movement increases as the daily injections are given. The animal is sensitized by 
Day 8, when the movement stops increasing at around 10000 cm………………………………………….20 
 
Figure 11: This figure shows the movement for an n=4 of SHR animals being injected with 
nicotine. The movement increases as the daily injections are given. . The animal is sensitized by 
Day 7 when the movement stops increasing at around 14000 cm…………………………………………...20 
 
Figure 12: This figure shows the movement for an n=4 of SD animals being injected with nicotine 
with an added stress. The movement increases as the daily injections are given. . The animal is 
sensitized by Day 6 when the movement stops increasing at around 4500 cm………………………….21 
 
Figure 13: This figure shows the movement for an n=4 of WKY animals being injected with 
nicotine with an added stress. The movement increases as the daily injections are given. The 
animal is sensitized by Day 5 when the movement stops increasing at around 4000 cm……………21 
 
Figure 14: This figure shows the movement for an n=4 of SHR animals being injected with 
nicotine. The movement increases as the daily injections are given. . The animal is sensitized by 
Day 4, when the movement stops increasing at around 6000 cm……………………………………………22 
 
Figure 15: This figure shows the movement for an n=4 of SD animals being applied only a stress. 
The movement increases, and then appears to normalize at around 8000 cm………………………....22 
 
Figure 16: This figure shows the movement for an n=4 of WKY animals being applied only a 
stress. The movement increases, and then appears to normalize at around 4000 cm………………..23 
 5 
 
Figure 17: This figure shows the movement for an n=4 of WKY animals being applied only a 
stress. The movement increases, and then appears to normalize at around 8000 cm……………….23 
 
Figure 18: This figure shows the parts of the reward system of the brain, which is normally 
activated when a drug is given…..…………………………………………………………………………………………24 
 
Figure 19: The figure above shows the activation in the WKY rat, the control, in the reward system 
of the brain for an acute nicotine dosage…………..………………………………………………………………….25 
 
Figure 20: The figure above shows the activation in the SHR rat, the ADHD model, in the reward 
system of the brain for an acute nicotine dosage.……………………………..……………………………………25 
 
Figure 21: The figure above shows the activation in the WKY rat, the control, in the reward system 
of the brain once it has been sensitized…………………………………………………………………………………26 
 
Figure 22: The figure above shows the activation in the SHR rat, the ADHD model, in the reward 
system of the brain once it has been sensitized……………………………………………………………….....…26 
 
Figure 23: This figure shows the % change in movement comparing WKY in red to SHR in 
blue....................................................................................................................................................28 
 
Figure 24: This figure shows the % of activated voxels in each of the brain areas listed in the 
reward system regions in the control (red) and the ADHD model rat (blue)…………………………….28 
 
Figure 25: This figure shows the % of activated voxels in each of the brain areas listed cortical 
regions (senses) in the control (red) and the ADHD model rat (blue)………………………………….…..29 
 6 
Abstract 
 
 While the percentage of smokers has decreased among the common 
population, the percentage of smokers suffering from attention-deficit 
hyperactivity disorder has almost doubled.  Psychological stressors may increase 
the desire to smoke among smokers, as well as lead to relapse after quitting.  The 
effects of stress on both conditions (ADHD and nicotine addiction) are a topic 
that deserves more investigation. This simultaneous presence of two or more 
conditions in a single individual is called comorbidity. When more than one 
condition co-occurs, the consequences of the conditions may affect a person 
differently than when the condition occurs in singularly.  
 This coexistence of conditions can be investigated using animal models. 
The genetics of a typical laboratory rat can be altered to simulate an ADHD 
sufferer, while an unaltered rat was used as a non-ADHD sufferer. A stress was 
applied, nicotine was administered, and behavioral sensitization was measured 
by locomotion. Once the rats were sensitized to the nicotine, they were imaged 
using functional magnetic resonance imaging to provide a picture of the effects 
the combination of ADHD, nicotine, and stress on the brain. This should 
corroborate the behavioral data gathered from locomotion. 
 It is hypothesized that nicotine sensitization will be greater in the ADHD 
model than in the non-ADHD model. With the presence of stress, this 
sensitization will occur still greater. The addition of stress to the situation is 
predicted to amplify sensitization. This means the addition of stress should 
increase the amount of movement and increase sensitization rate. The data 
showed a greater nicotine sensitization for the ADHD model compared to the 
non-ADHD model, the control. However, sensitization was not amplified when 
stress was coupled to nicotine for both models.  The fMRI results corroborated 
these findings.    
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Introduction 
  
 While the percentage of smokers has decreased, the percentage of smokers 
among those suffering from attention-deficit hyperactivity disorder (ADHD) has 
almost doubled. Psychological stressors may increase the desire to smoke among 
smokers, as well as lead to relapse after quitting. The property that causes this 
addiction to smoking and effects on the brain is found in the nicotine contained 
in cigarettes. The effects of stress on nicotine addiction in ADHD sufferers are a 
topic that deserves more investigation. This coexistence of two or more 
conditions in a single individual is called comorbidity. When more than one 
condition co-occurs, the consequences of the conditions may affect a person 
differently than when the conditions occur singularly.  
  
 Background 
 
 Attention-deficit/hyperactivity disorder, better known as ADHD, is a 
disorder with many possible contributing factors including strong genetic roots.1 
ADHD is physically demonstrated in a person by daydreaming, distractibility, 
and difficulty focusing on a single task for a prolonged period in the attention 
deficit component; the hyperactivity component is demonstrated by fidgeting, 
excessive talking, and restlessness. The symptoms of ADHD have been shown to 
cause accidents, cause strain in personal relationships, and disrupt the 
environment through interruptions and inappropriate behavior, not just for those 
with the disorder, but everyone. 2 
 Studies on whole families have shown that heredity plays a major role in 
the onset of ADHD. Family studies have demonstrated a two to eight times 
increase in the risk for ADHD in parents and siblings of children with ADHD as 
can be seen in the chart below3:  
 
 
Figure 1: This graph shows the high probability that a parent with ADHD will pass that disorder onto their 
offspring versus a parent without ADHD in three different studies. 
 
While conducting studies that involve the control of drug addiction, there have 
been families involved that have shown that genes can also contribute to the 
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vulnerability of addictive diseases/disorders. This was first shown with 
alcoholism, which is specifically enhanced by an aldehyde dehydrogenase 2 
genotype. Since then, there have been genes associated with the opioid system, 
serotonergenic system and more. 4  These and other data offer the suggestion that 
persistent ADHD might be a useful phenotype for molecular genetic studies such 
as this study to determine effects of stress on an ADHD model, i.e. the 
spontaneously hypertensive rats (SHR), to determine any change in patterns of 
addiction. Different strains, or different rat models, are able to show the 
differences in the cellular and molecular responses under different conditions.  
 Stress is defined as a medical term for strong external stimuli, both 
physiological and psychological, which can cause a physiological response called 
the general adaptation syndrome. This general adaptation syndrome causes heart 
rate, blood pressure and respiration to rise and the “flight or fight” mechanism to 
deploy.5  
 Stress has been shown to be one of the most common features reported to 
cause a relapse in smoking.6 After quitting, the most common side effects are 
anxiety, irritability, depression, and craving, which are intensified by stress. 
Stress has also been shown to increase smoking among current smokers and 
speeds up the progression of a possible relapse to smokers after quitting. The 
exact causes of these events due to stress that impact a relapse are not positively 
known. However, recent advancements in scientific research suggest that many 
neuroendocrine, psychosocial, and biobehavioral mechanisms all act with stress 
effects on relapse7. 
 When a smoker stops smoking, he/she experiences symptoms like 
irritability, craving, anxiety, depression, restlessness, and difficulty 
concentrating. These symptoms begin almost immediately after the nicotine is 
taken away, within the first twenty-four hours. These effects of the lack of 
smoking on mood may be part of what causes a high level of stress, and hence 
could increase the desire to smoke8. 
 The effects that acute doses of nicotine have on the hypothalamic–
pituitary adrenocortical (HPA) axis have been documented previously and are 
shown to be a stimulant. Following nicotine administration, dose-dependent 
increases in brain activity have been noted in regions involved in emotion 
regulation and HPA responses to stress.9 Exposure to stress also activates the 
HPA axis, and the activation or lack of activation impacts addiction.10 Nicotine 
also activates the HPA axis, and increased HPA activity has been linked to 
attenuated CNS nicotinic receptor sensitivity.11 This connection is one reason 
research involving the differences in stress response between smokers and non-
smokers is necessary. In previous animal models, it was shown that in previous 
animal models stressors have influenced the reinforcing effects of a drug of 
abuse.12   
 A susceptibility to developing a drug addiction is influenced by many 
factors including ones from genetics and environment. However, the effects 
directly from the drug also affect the progression of addiction, as well as the 
tendency to quit and relapse after being clean for a long time period. Rates of 
cigarette smoking are the highest among patients with psychotic and substance-
use disorders, but it is also high for depression, anxiety, and personality 
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disorders. Both children and adults with ADHD are significantly more likely to 
smoke than people without the disorder. In a laboratory environment, nicotine 
has been previously shown to reduce the symptoms of ADHD because it acts as a 
dopamine agonist. This sort of positive reinforcement encourages smoking 
among these ADHD sufferers. 13 
 After multiple administrations of a drug of abuse, there is an increase in 
psychomotor stimulant effects and positive reinforcing effects, where a 
psychomotor stimulant is defined as a group of drugs, including cocaine, 
amphetamine, methylphenidate, and ephedrine that produce an awakening effect 
and stimulate behavior. This set of events is defined as behavioral sensitization 
and occurs with repeated use of substances of abuse. Results of locomotor tests 
suggest long term effects of the repeated use of nicotine.14 One study’s 
preliminary work demonstrates that are differences in locomotor sensitization 
among inbred mouse strains. In other words, there are differences in locomotor 
sensitization among the different genetic models. Studies on these inbred strains 
could possible be able to clarify what genes do in response to nicotine-induced 
sensitization.15 
 It is believed that drug-induced behavioral sensitization is an important 
process in the development of a substance addiction. Repeated injections of 
nicotine produce gradual increases in locomotor activity in rats and mice which is 
considered behavioral sensitization. Nicotine-induced sensitization has been 
widely studied using this model, because sensitization is believed to be an 
important process in the development of drug addiction. The model has been in 
use since 1984. The repeated injections of nicotine that produce behavioral 
sensitization result in an increase of extracellular dopamine release in the 
nucleus accumbens and the striatum. It is likely nicotine-induced sensitization 
changes not only neural transmission, but also gene expression in the mesolimbic 
system.16 It is important to explore these areas using functional magnetic 
resonance imaging (fMRI) to see the exact changes in the ADHD brain as a result 
of smoking compared to the changes in the brain as a result of smoking AND 
stress.    
 Because of the effects drug sensitization, specifically nicotine sensitization, 
as well as stress and genetics, have on the neuronal mechanisms, as well as 
behavioral symptoms, it appears that more research is needed on the 
connections. Specifically, the effect of stress on nicotine sensitization on an 
ADHD rat model compared to a “typical rat” model will be investigated. 
 Models are a tried and true method used to predict what will happen in 
“real life”. Architects make models of buildings before they build a life size 
building to predict if the building will successfully stand. If the model breaks or 
cracks in certain places, the blueprints for the building will have to be updated. 
Without a model, people could be hurt using this building under unsafe 
conditions. This idea can also be translated into science. Drugs are tested on 
animal models to see the effects that the drug would have on a range of people. 
Devices are tested on animals to see if they perform their duty properly and 
comfortably. Models also allow the investigator to have control of the 
environment. In this case, using models will enable a prediction of what would 
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happen in humans under these very common human conditions in a controlled 
environment. 
 The main type of rat used in research is the Sprague-Dawley (SD) rat. By 
manipulating the genes in this rat, scientists have created a way to model some 
genetically based human conditions. To create a successful model of attention 
deficit and hyperactive disorder (ADHD), needed for this study, where the 
symptoms are all behavioral, there are multiple areas in the brain that control the 
behavior that need to be examined to get the precise combination of effects that 
make up ADHD. These symptoms must be comparative to the human symptoms 
of ADHD in order to be a successful model. 
 
 Animal Modeling 
 
 To create a successful animal model certain criteria must be met. Validity 
and reliability are the two factors on which animal models are evaluated. There 
are four aspects to validity: face, predictive, etiological and genetic.  Face validity 
describes the similarity between the animal model and a specific human 
behavior. Although the behavior of the human behavior and the animal behavior 
do not need to be exactly similar, the behavior should be comparable. Predictive 
validity describes the extent that an animal model will allow predictions to be 
made about the human behavior, or how useful the model will be. Etiological 
validity focuses on the similarity between mechanisms that are involved in the 
behavior of the animal model and the human. Genetic validity is present when 
the genetic component in both humans and the animal model is similar. In most 
psychiatric disorders, there is a genetic component. The reliability refers to the 
stability and reproducibility of the model. 17 
 For an ADHD model, the above criteria can be made more specific. For 
face validity, the model should mimic the fundamental behavioral characteristics 
of ADHD. For instance, impulsiveness should be absent initially and develop 
gradually over time, sustained attention-deficit should be demonstrated only 
when stimuli are widely spaced in time, hyperactivity should not be observed in a 
novel, non-threatening environment and it should also develop over time. In 
terms of etiological validity, an ADHD model should demonstrate the two main 
behavioral patterns have been shown to be major contributory factors in the 
origin of ADHD: altered reinforcement of novel behavior and deficient extinction 
of previously reinforced behavior. The model should predict aspects of ADHD 
behavior to show predictive validity and the model should be preferably a genetic 
model. 18 
 The ADHD model, SHR, shows these listed behavioral characteristics of an 
ADHD sufferer: impaired sustained attention without obvious sensory problems, 
motor impulsiveness, and hyperactivity that develops over time when reinforcers 
are not frequent. Just like children with ADHD, SHRs display increased 
behavioral variability, deficient response re-engagement, and make a greater 
amount of error than controls. Besides adhering to behavioral criteria for an 
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animal model of ADHD, SHR fulfils the genetic validity statement in that it is a 
genetic model of ADHD bred from the WKY rats, where WKY serve as a valid 
control for SHR since their behavioral characteristics are similar to those of other 
rat strains. SHR rats were originally used as hypertension models as they age, 
however, while in adolescence, they show the symptoms of ADHD. WKY rats are 
widely used as a control for hypertension. 
 The theory to get this specific model of ADHD is based on the hypothesis 
that altered dopaminergic function doesn’t adjust the nondopaminergic signal 
transmission correctly. A hypofunctioning mesolimbic dopamine receptor will 
give a behavior that shows delayed aversion, development of hyperactivity in 
novel situations, impulsiveness, deficient sustained attention, increased 
behavioral variability, and failure to reduce responses. A hypofunctioning 
mesocortical dopamine receptor will cause attention response deficiencies.19 For 
instance, if the animal is placed in a box with an object somewhere in the box, the 
non-ADHD model rat will take the straightest path to the object, while the ADHD 
model will take detours, but eventually end up in the same place. Other attention 
response deficiencies include flawed orienting responses, impaired eye 
movements, and poor behavioral planning. A hypofunctioning nigrostriatal 
dopamine branch will cause impaired motor functions and a lacking implicit 
habit learning and memory. These deficiencies give rise to apparent 
developmental delay, clumsiness, and small abnormalities in sensory and motor 
responses when quick reactions are required. These symptoms all together will 
give an ADHD model that is comparative to the human standards of what ADHD 
is.  
 Three candidate dopamine genes (DRD2, DRD4, and DAT) were 
sequenced in SHR and WKY. No differences were found in DRD2 or DRD4 genes 
but a 160 blood pressure insertion was found in the non-coding region upstream 
of axon 3 of the DAT1 gene. This is where the differences lie, genetically, between 
the WKY and the SHR rats. The DAT gene has been associated with ADHD in 
several family studies. Alterations in DAT1 gene expression can affect dopamine 
uptake and reutilization. For example decreases in the expression of DAT1 will 
reduce reuptake and increase metabolism of dopamine. Differences in dopamine 
metabolism have been reported for children and adults with ADHD DOPA 
decarboxylase activity was found to be increased in the midbrain of children and 
decreased in prefrontal cortex of adults with ADHD compared to controls. 
Reduced DAT1 expression at a young age would reduce dopamine reuptake, 
thereby reducing dopamine reutilization and necessitating increased synthesis of 
dopamine by DOPA decarboxylase. In adults, increased expression of DAT1 
might be expected to increase reuptake of dopamine, thereby reducing the need 
for synthesis by DOPA decarboxylase.20 
 SHR appear to have higher extracellular tonic dopamine in the nucleus 
accumbens shell. However, consistent with increased DAT1 expression in adult 
SHR striatum, extracellular dopamine levels are decreased in the caudate nucleus 
and d-amphetamine-stimulated release of dopamine via DAT1 is greater in SHR 
striatum than WKY. These findings suggest that increased expression of the DAT1 
gene may reflect an attempt to compensate for increased tonic extracellular 
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dopamine in the nucleus accumbens shell of SHR or increased DAT1 expression 
may occur in an attempt to compensate for decreased function of DAT1 in adult 
SHR striatum.21 
 Hypertension is a confounding factor in the SHR model of ADHD. 
However, SHR do not develop hypertension until they are adults, from 10 to 12 
weeks of age, whereas hyperactivity is observed at 3 to 4 weeks of age before they 
enter puberty. Analysis of their behavior revealed that locomotion mapped to 
chromosomes 3, 8 and 18 while hypertension exhibited multigenic complexity 
with both environment and genetic background as contributing factors. SHR 
behavior was suggested to result from an interaction between genetics and the 
environment, much like ADHD.22 
 In addition to behavioral and genetic similarities to ADHD, SHR exhibit 
brain pathology similar to ADHD. SHR brain volumes, specifically prefrontal 
cortex, occipital cortex, and hippocampus, are smaller than controls. MRI 
revealed significantly increased ventricular volume in SHR compared to WKY at 
3 months of age. There are fewer neurons in these brain areas compared to WKY. 
Taken together, these studies point to a definitive genetic link between SHR and 
ADHD individuals.  
  Expected Results 
 
 The objective of this experiment is to determine the effects of stress and 
nicotine sensitization separately and jointly on an ADHD model and control 
models. The hypothesis states that the rats considered to be the ADHD model will 
sensitize to nicotine greater than non ADHD rats. With an added stress, it is 
expected that both sets of rats will sensitize greater still. Quantitatively, stress 
will make the ADHD models move a greater total distance and sensitize faster. 
The non ADHD models will also increase locomotion due to stress, but not to the 
same degree as the ADHD models.   
 In total, there are six different sets of rats: SD without stress, SD with 
stress, WKY without stress, WKY with stress, SHR without stress and SHR with 
stress. Each of these rats is a different model, and hence will each have different 
results. The expected results for the precursor (WKY) and the ADHD model 
(SHR) are shown, graphically. 
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Figure 2: This figure shows the expected movement of each of the six sets of rats versus time, with the time 
on the x-axis and the movement on the y-axis.  
 
Methods 
 Subjects 
 
 Three types of rats were used. These include a model for ADHD (SHR), the 
genetic precursor to the ADHD models (WKY), and the original species of rat, 
Sprague-Dawley, or SD.  These rats were divided into two groups of each rat type, 
saline and nicotine. The nicotine group was then subdivided into two groups of 
stress and no stress, and another group was added to consider stress alone. 
 
 Equipment 
  Behavioral 
 
 To measure the movement of the subjects, they were each placed into a 
clean, black box. Above the box was a camera to track the subject. A computer is 
attached to this camera and contains a program called Ethovision, which was 
used to automatically record the activity levels (distance traveled), and then 
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export this raw data to an Excel sheet.  This setup can be seen below in the 
following figure. 
                                                  
 
Figure 3: The animals were placed in the black box above to gather the behavioral data for this study. 
 
  fMRI 
 
 Functional magnetic resonance imaging was conducted using a Brucker 
Biospec 4.7-T/40 cm horizontal magnet equipped with a Biospec Brucker console 
and a 20 G/cm magnetic field gradient insert. Images will all be obtained with a 
BOLD-weighted multislice fast spin echo pulse sequence with the following 
parameters: 14 slices, 1.2 mm thick; field of view, 30 mm; 64x64 data matrix; 
echo train length (ETL), 16; echo spacing, 7 ms; repetition time (TR), 2108 ms; 
effective echo time, 7 ms.23 To contain the animals before placing the in the 
magnetic coil, the y were placed into a two-part coil system.  
 
  
 
 
  
 
 
 
Figure 4: Animals were secured with this  
multi-concentric dual-coil, small animal restrainer.    Figure 5: Once the particular animal was   
        secured, it was placed into the above magnet  
        for fMRI.  
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Procedure 
 
 Specifically, the progression of events was as such for each set of rats: 
 
    Event   Days 
Acclimation (to the 
MRI machine) 
3 
Habituation 
(acclimation to the 
environment and the 
injection) 
2 
Sensitization 
(administration of 
nicotine until 
distance traveled 
levels off) 
5-7 
Imaging 1 
 
These values come from research from outside journals as described below. 
 
 Experimental Protocol Time Table 
 
SHR                     WKY                           SD 
 
This table shows the dates of when the behavioral data was gathered. 
 fMRI 
 
 Functional imaging data shows high quality images of the inside of the 
human body. Magnetic resonance began as a tomographic imaging method for 
producing nuclear magnetic resonance (NMR) images of a slice through the body, 
where each slice has a certain thickness. A tomographic imaging method is one in 
which detailed x-rays of a predetermined plane section of a solid object are made 
while blurring out the images of other planes. The magnetic resonance image that 
is gathered is made up of many pixels. The intensity of a pixel is proportional to 
the intensity of the contents of the corresponding volume element of the object 
being imaged. The intensity being measured here is based on the absorption and 
emission of energy from the electromagnetic spectrum.24 
 
Nicotine (n=4) 08/05 Nicotine (n=4) 08/05 Nicotine (n=4) 06/05 
Saline (n=4) 08/05 Saline (n=4) 08/05 Saline (n=4) 06/05 
Nicotine+Stress 
(n=4) 
1/06 Nicotine+Stress 
(n=4) 
2/06 Nicotine+Stress 03/06 
Stress (n=4) 3/06 Stress (n=4) 03/06 Stress 03/06 
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  Acclimation Phase 
 
 When placing a rat into an MRI machine, acclimation prepares the rat for 
this experience. Acclimation is when the animal is placed in a restraint device 
similar to the one in an MRI machine. This is because being placed in a restraint 
is also a stressor for rats and hence changes the physiological response. When an 
animal is acclimated, it becomes used to the restraint and the act of this certain 
restraint is no longer a stress. In one experiment to determine how to acclimate 
rats to an MRI machine, the animals were acclimated for eight days and the heart 
rate gathered on interval. The results showed that by the 3rd day of acclimation, 
the heart rate had dropped to normal range, showing that the animal no longer 
experiences the physiological act of stress.25 
 Habituation Phase 
 
 Habituation is defined as a decline of a conditioned response following a 
repeated exposure to the conditioned stimulus, in this case, the stimulus being a 
new environment. Habituation is done to prevent the response of the unwanted 
stimulus to concentrate on the stimulus being studied.26 Previous to any nicotine 
injections, all of the rats will be habituated into the environment, as well as to a 
saline injection, for 30 minutes for two days. This will also allow a baseline to 
compare to the distances traveled after the nicotine injections begin. 
 It has been documented that habituation only takes one day in behavioral 
sensitization tests. For instance, in one study that sensitized the animals to 
nicotine also, all the animals were given saline on the first day, however by the 
second day; they were split into a “nicotine” group and a “saline” group.27 More 
than one study involving behavioral sensitization had the rats being habituated 
for one day to acclimate to the surroundings, and the following day meant for 
habituation to the injection.28,29 
 
 Sensitization 
 
 Sensitization is defined as increase in responsiveness upon repeated 
exposure to a stimulus, the stimulus being nicotine. This is demonstrated by the 
increase in locomotion that is measured. When the locomotion quantity has 
leveled off, the animal has been sensitized to the stimulus, nicotine.  
  
  Drug Administration 
 
 A subcutaneous injection of .4 mg/kg nicotine was used. Previous research 
has shown this number to be most commonly used in subcutaneous injections.30 
Intramuscular injections and intravenous injections were eliminated because rats 
have limited muscle mass and the skin overlying the vessels in the adult rat is 
very thick, making injections difficult. Subcutaneously injected drugs will begin 
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their effects within 5 minutes.31 When the nicotine solution is mixed, it is tested 
as to achieve a pH of 7. This is done because the pH of 7 is a neutral pH which 
won’t cause any internal reactions when injected. Both groups of each type of rat 
were exposed to daily nicotine injections; however, one group (a nicotine + stress 
group) was also given a stress. The injections were given daily for 5 days, which 
personal previous research has shown to achieve sensitization in these rats.  The 
rats were, immediately following the injection, placed into the box where the 
movement data was acquired for 30 minutes.  
 
  Stress Manipulation 
 
 Stress is thought to expedite the process of sensitization, although, some 
data has shown that this is only the case for adult female rats, not adult male rats. 
Each rat in the stress group was subject to a stress of an air puff for just one puff 
(1-2 seconds) immediately following the injection to investigate the hypothesis. 
This stress of an air puff was chosen because in past research, it has been 
observed to elicit this response in rats. The air puff has been shown to cause 
submaximal cardiovascular changes in rats, and to double the heart rate in 
Sprague-Dawley rats, as well as activate the HPA axis.32 From personal 
observation, the behavior following the air puff has appeared to be an increase 
heart rate and freezing of the rat, meaning the rat stops all movement, although 
there was no quantitative measurement. 
  
Results 
 Sensitization 
 
 The results of the nicotine sensitization are graphically presented below, 
with the standard deviation of n-1 shown. The results for saline only animals are 
presented first: SD, WKY and SHR, respectively.  Next are the results for the 
nicotine only animal groups, in the same order as above. Then, shown are the 
results for these animals under a stress with nicotine, again in the same order, 
and lastly shown are the results for each set of animals under a stress alone. 
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Figure 6: This figure shows the movement for an n=4 of SD animals being injected with only saline. The 
movement stays basically constant at an average distance of 8500 cm.  
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Figure 7: This figure shows the movement for an n=4 of WKY animals being injected with only saline. The 
movement stays basically constant at an average distance of 5000 cm.  
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Figure 8: This figure shows the movement for an n=4 of SHR animals being injected with only saline. The 
movement stays basically constant at an average distance of 8000 cm. 
 
The nicotine injections begin on Day 3, with the first two days as habituation. 
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Figure 9: This figure shows the movement for an n=4 of SD animals being injected with nicotine. The 
movement increases as the daily injections are given. The animal is sensitized by Day 6, when the movement 
stops increasing and around 11000 cm. 
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Figure 10: This figure shows the movement for an n=4 of WKY animals being injected with nicotine. The 
movement increases as the daily injections are given. The animal is sensitized by Day 8, when the movement 
stops increasing at around 10000 cm. 
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Figure 11: This figure shows the movement for an n=4 of SHR animals being injected with nicotine. The 
movement increases as the daily injections are given. . The animal is sensitized by Day 7 when the movement 
stops increasing at around 14000 cm. 
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The nicotine injections and the stress are both introduced on the third day, with 
the first two days as habituation. 
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Figure 12: This figure shows the movement for an n=4 of SD animals being injected with nicotine with an 
added stress. The movement increases as the daily injections are given. . The animal is sensitized by Day 6 
when the movement stops increasing at around 4500 cm. 
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Figure 13: This figure shows the movement for an n=4 of WKY animals being injected with nicotine with an 
added stress. The movement increases as the daily injections are given. . The animal is sensitized by Day 5 
when the movement stops increasing at around 4000 cm. 
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Figure 14: This figure shows the movement for an n=4 of SHR animals being injected with nicotine. The 
movement increases as the daily injections are given. . The animal is sensitized by Day 4, when the 
movement stops increasing at around 6000 cm.  
 
Figures 12-14 show a leveling off of locomotor activity more rapidly and are 
contrary of what was predicted in the hypothesis. 
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Figure 15: This figure shows the movement for an n=4 of SD animals being applied only a stress. The 
movement increases, and then appears to normalize at around 8000 cm. 
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Figure 16: This figure shows the movement for an n=4 of WKY animals being applied only a stress. The 
movement increases, and then appears to normalize at around 4000 cm.  
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Figure 17: This figure shows the movement for an n=4 of WKY animals being applied only a stress. The 
movement increases, and then appears to normalize at around 8000 cm.  
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 fMRI 
 
 The functional magnetic resonance imaging was conducted for an acute 
dosage of nicotine and also for nicotine sensitized animals of both WKY and SHR 
(both cases).  Below presented is an image for each group of animals showing the 
activity in the reward system regions of the brain. The reward system of the brain 
contains the areas that are typically activated when a drug is given and motivates 
people to seek the substances that give pleasure and avoid substances that give 
physical discomfort, depression or social isolation. 33 
 
                                  
 
Figure 18: This figure shows the parts of the reward system of the brain, which is normally activated when a 
drug is given. 
 
 Out of the areas activated, the ventral tegmental area (VTA), the 
accumbens, and the prefrontal cortex play the most crucial roles in this system. 
For nicotine specifically, the areas most affected are the hippocampus and the 
cortex, which explains the increase in awareness and attentiveness that smokers 
report they feel.34  
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Figure 19: The figure above shows the activation in the WKY rat, the control, in the reward system of the 
brain for an acute nicotine dosage.  
 
 
                                         
Figure 20: The figure above shows the activation in the SHR rat, the ADHD model, in the reward system of 
the brain for an acute nicotine dosage.  
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Figure 21: The figure above shows the activation in the WKY rat, the control, in the reward system of the 
brain once it has been sensitized. 35 
 
 
                                       
 
Figure 22: The figure above shows the activation in the SHR rat, the ADHD model, in the reward system of 
the brain once it has been sensitized. 36 
 
Data Analysis 
 Sensitization 
 
 From the above figures, it is shown that as a baseline, the movement for 
the SD rat stays basically constant at an average distance of 8500 cm. The 
movement for the WKY stays basically constant at an average distance of 
5000 cm, and the movement for SHR at 8000 cm. The movement increases 
as the daily injections of nicotine are given and the SD animal is sensitized by 
day 6, when the movement stops increasing at about 11000 cm. The WKY 
animals are sensitized by Day 8, when the movement stops increasing at 
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around 10000 cm and the SHR animals are sensitized by Day 7 when the 
movement stops increasing at around 14000 cm. Finally, with the added 
stress, the movement once again increases as the daily injections of nicotine 
are given, however, at a faster rate. The SD animals are sensitized by Day 6, 
when the movement stops increasing at about 4000 cm. The WKY animals 
are sensitized by Day 5, when the movement stops increasing at around 4000 
cm and the SHR animals are sensitized by Day 4 when the movement stops 
increasing at around 6000 cm. This data is summarized below, and it is easy 
to see the differences in locomotion between the rats in each circumstance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The difference in intensity of sensitization between the WKY rat, which is 
considered to be more the control, and the SHR rat, the ADHD model, can be 
better seen with a percent change graph.  Although both animals have 
approximately the same change by day 4, the SHR rat reaches this point much 
faster.  
 
 Saline 
 WKY: 5,000 cm. 
 SHR: 8,000 cm. 
 SD: 8,500 cm. 
 Nicotine 
 WKY: 10,000 cm. 
 SHR: 14,000 cm. 
 SD: 11,000 cm. 
 Nicotine + Stress 
 WKY: 4,000 cm. 
 SHR: 6,000 cm. 
 SD: 4,500 cm. 
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Figure 23: This figure shows the % change in movement comparing WKY in red to SHR in blue. 
 MRI 
 
 The fMRI images shown above can be graphically represented, showing 
the percentage of activity in each specific brain region of the reward system. 
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Figure 24: This figure shows the % of activated voxels in each of the brain areas listed in the reward system 
regions in the control (red) and the ADHD model rat (blue). 
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As can be seen, there is very little to no difference in the percentage of activity in 
these regions, although the SHR has greater activity.  However, from the images 
gathered, there is a clear difference in brain activity between the WKY and the 
SHR. Looking specifically at nicotine, it was already mentioned that the cortex is 
one of the areas most affected. This is confirmed by the graph below.  
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Figure 25: This figure shows the % of activated voxels in each of the brain areas listed cortical regions 
(senses)  in the control (red) and the ADHD model rat (blue). 
 
Both models the experience the nicotine as a reward, so there is no difference 
brain activation in the reward system. However, the ADHD model shows 
decrease in activation in cortical regions. 
Conclusion 
 
 Behaviorally, movement increased for both the ADHD and control models 
when administered nicotine, and when stress was added, the movement for both 
groups was reduced to below the baseline average values.  A more rapid 
sensitization was measured in both animal models with stress. The ADHD model, 
SHR rat, sensitized to nicotine more quickly than the control under the stress and 
non-stress conditions. For the acute nicotine dose that was given during the 
fMRI, the ADHD model showed less activation in the brain than the control. The 
data showed a greater nicotine sensitization for the ADHD model compared to 
the non-ADHD model, the control. However, sensitization was not amplified 
when stress was coupled to nicotine for both models, contrary to the hypothesis.  
The fMRI results corroborate these findings. This study was intended to be a pilot 
study, with the fMRI data showing that there are corresponding neurological 
changes paired with the behavioral data.     
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